KU Hematology & Medical Oncology Review 2019
KU ASCO Review 2019: FDA Approval of Daratumumab in Combination with Len-Dex for Newly Diagnosed, Transplant-Ineligible Patients with Multiple Myeloma
Comments 0
Login to view comments.
Click here to Login
